Thermo Fisher Scientific (TMO) revenue breakdown
By segment, Laboratory Products and Biopharma Services is the largest at 53% of fiscal 2025 revenue, growing 15% a year over 8 years.
By product, Consumables is the largest at 42% of fiscal 2025 revenue; Service revenues grew fastest, 23% a year over 8 years.
Revenue by segment
Fiscal years, as Thermo Fisher Scientific reports them in its 10-K filings; fiscal 2025 total $44.6B.
| Segments | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| Laboratory Products and Biopharma Services | $7.8B | $10.0B | $10.6B | $12.2B | $14.9B | $22.3B | $22.9B | $23.0B | $23.8B | 53% |
| Life Sciences Solutions | $5.7B | $6.3B | $6.9B | $12.2B | $15.6B | $11.6B | $8.5B | $8.2B | $8.8B | 20% |
| Analytical Instruments | $4.8B | $5.5B | $5.5B | $5.1B | $6.1B | $6.4B | $7.1B | $7.3B | $7.4B | 17% |
| Specialty Diagnostics | $3.5B | $3.7B | $3.7B | $5.3B | $5.7B | $4.6B | $4.3B | $4.4B | $4.6B | 10% |
Revenue by product
Fiscal years, as Thermo Fisher Scientific reports them in its 10-K filings; fiscal 2025 total $44.6B.
| Products | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| Consumables | — | $12.6B | $13.1B | $18.5B | $22.6B | $20.6B | $17.6B | $17.6B | $18.7B | 42% |
| Service revenues | $3.5B | $5.5B | $6.0B | $6.9B | $8.8B | $16.4B | $17.6B | $17.8B | $18.6B | 42% |
| Instruments | — | $6.3B | $6.4B | $6.8B | $7.8B | $7.9B | $7.6B | $7.4B | $7.3B | 16% |
| Product | $17.4B | — | — | — | — | — | — | — | — | — |
Revenue by region
Fiscal years, as Thermo Fisher Scientific reports them in its 10-K filings; fiscal 2025 total $44.6B.
| Regions | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| North America | — | $12.1B | $12.9B | $17.1B | $19.7B | $24.6B | $22.8B | $22.5B | $23.0B | 52% |
| Europe | — | $6.2B | $6.4B | $8.3B | $11.1B | $10.8B | $10.7B | $10.9B | $11.8B | 27% |
| Asia-Pacific | — | $5.2B | $5.5B | $5.8B | $7.2B | $8.1B | $7.9B | $8.0B | $8.1B | 18% |
| Other regions | — | $750M | $764M | $1.0B | $1.2B | $1.4B | $1.5B | $1.6B | $1.6B | 4% |
| United States | $10.1B | — | — | — | — | — | — | — | — | — |
| All Other Countries | $8.7B | — | — | — | — | — | — | — | — | — |
| China | $2.1B | — | — | — | — | — | — | — | — | — |
Questions
Where does Thermo Fisher Scientific make its money?
In fiscal 2025, by segment: Laboratory Products and Biopharma Services $23.8B, Life Sciences Solutions $8.8B, Analytical Instruments $7.4B, Specialty Diagnostics $4.6B.
From Thermo Fisher Scientific's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.